|
Volumn 61, Issue 11 SUPPL. 6, 2003, Pages
|
III. A2A receptors in neuroprotection of dopaminergic neurons
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE;
ADENOSINE A2 RECEPTOR;
ADENOSINE A2 RECEPTOR ANTAGONIST;
CAFFEINE;
GLUTAMIC ACID;
ISTRADEFYLLINE;
OXIDOPAMINE;
ADENOSINE A2A RECEPTOR;
DOPAMINE;
ENZYME INHIBITOR;
NEUROPROTECTIVE AGENT;
PURINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
TRIAZOLE DERIVATIVE;
CLINICAL FEATURE;
DIET;
DISEASE COURSE;
DOPAMINERGIC NERVE CELL;
DRUG EFFECT;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
NERVE CELL DEGENERATION;
NEUROPROTECTION;
NIGRONEOSTRIATAL SYSTEM;
NONHUMAN;
PARKINSON DISEASE;
PRESYNAPTIC NERVE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SUBSTANTIA NIGRA;
WILD TYPE;
ANIMAL;
CONFERENCE PAPER;
DISEASE MODEL;
DOSE RESPONSE;
DRUG ANTAGONISM;
FEMALE;
MALE;
METABOLISM;
NERVE CELL;
SEX DIFFERENCE;
ANIMALS;
CAFFEINE;
DISEASE MODELS, ANIMAL;
DOPAMINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
MALE;
NEURONS;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
PURINES;
PYRIMIDINES;
RECEPTOR, ADENOSINE A2A;
SEX FACTORS;
TRIAZOLES;
|
EID: 0344738721
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000095212.19029.04 Document Type: Editorial |
Times cited : (14)
|
References (12)
|